Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Check-Cap Ltd. (NASDAQ: CHEK).

Full DD Report for CHEK

You must become a subscriber to view this report.


Recent News from (NASDAQ: CHEK)

Check-Cap reports Q3 results
Check-Cap (NASDAQ: CHEK ): Q3 GAAP EPS of -$0.50  beats by $0.03 . More news on: Check-Cap Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: November, 05 2018 07:09
Check-Cap Reports Third Quarter 2018 Financial Results
ISFIYA, Israel , Nov. 5, 2018 /PRNewswire/ --  Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, a preparation free capsule-based screening method...
Source: PR Newswire
Date: November, 05 2018 06:53
Your Daily Scoop: Recro Proceeds, MannKind Zooms, Aduro's Publication
News in focus: REPH, MNKD Recro Pharma plans to resubmit NDA Discussion : On September 4, Recro Pharma ( REPH ) reported positive outcome of its meeting with the FDA regarding its NDA for IV meloxicam that was rejected in last May. Based on the discussion with the FDA, the comp...
Source: SeekingAlpha
Date: September, 07 2018 16:31
Check-Cap Receives Approval From the Israeli Ministry of Health to Initiate Commercial Sales in Israel of its C-Scan® System
ISFIYA, Israel , Sept. 5, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan ® , an ingestible capsule for preparation-free, colorectal...
Source: PR Newswire
Date: September, 05 2018 07:00
Premarket Gainers as of 9:05 am (9/4/2018)
MNKD   +47%  on collaborating with United Therapeutics for pulmonary hypertension products. More news on: MannKind Corporation, TravelCenters of America LLC, Recro Pharma Inc, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 04 2018 09:24
Check-Cap Announces Promising Interim Results from its Ongoing Post-CE Approval Study of C-Scan® System Version 3
ISFIYA, Israel , Sept. 4, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan ® , an ingestible capsule-based device for preparatio...
Source: PR Newswire
Date: September, 04 2018 07:00
Check-Cap Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference
ISFIYA, Israel , Aug. 29, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule-based device for preparation-free col...
Source: PR Newswire
Date: August, 29 2018 08:00
Check-Cap reports Q2 results
Check-Cap (NASDAQ: CHEK ): Q2 EPS of -$1.74. More news on: Check-Cap Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: July, 31 2018 07:10
Check-Cap Reports Second Quarter 2018 Financial Results
ISFIYA, Israel , July 31, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule-based device for preparatio...
Source: PR Newswire
Date: July, 31 2018 07:00
Free Research Reports on DexCom and Three More Medical Research Stocks
Stock Research Monitor: CGIX, CHEK, and EXAS LONDON, UK / ACCESSWIRE / July 12, 2018 / If you want a free Stock Review on DXCM sign up now at www.wallstequities.com/registration . Today's research on WallStEquities.com is focused on Cancer Genetics Inc. (NASDAQ: CGIX ), Check-Cap Ltd ...
Source: ACCESSWIRE IA
Date: July, 12 2018 07:25

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-143.182.953.28442.85147,069
2018-12-133.453.203.983.121,069,746
2018-12-123.263.253.303.1211,331
2018-12-113.143.2013.383.135613,256
2018-12-103.213.203.44033.1619,951

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1417,05338,25944.5725Short
2018-12-13100,581180,74255.6489Short
2018-12-128971,82249.2316Short
2018-12-112,5667,70033.3247Cover
2018-12-1010,10012,45181.1180Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CHEK.


About Check-Cap Ltd. (NASDAQ: CHEK)

Logo for Check-Cap Ltd. (NASDAQ: CHEK)

Not available

 

Contact Information

 

 

Current Share Structure

     


    Recent Filings from (NASDAQ: CHEK)

    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 17 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 08 2018
    Prospectus filed under Rule 424(b)(4)
    Filing Type: 424B4Filing Source: edgar
    Filing Date: May, 07 2018
    Registration of up to an additional 20% of securities for an offering filed on an F-1
    Filing Type: F-1MEFFiling Source: edgar
    Filing Date: May, 04 2018
    Post-effective amendment to an S-Type filing
    Filing Type: POS AMFiling Source: edgar
    Filing Date: May, 04 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 04 2018
    Registration of certain classes of securities 12(b) of the Securities Exchange Act
    Filing Type: 8-A12BFiling Source: edgar
    Filing Date: May, 03 2018
    Filing Type: CERTFiling Source: edgar
    Filing Date: May, 03 2018
    This filing is a pre-effective amendment to an F-1 filing
    Filing Type: F-1/AFiling Source: edgar
    Filing Date: May, 02 2018
    Post-effective amendment to an S-Type filing
    Filing Type: POS AMFiling Source: edgar
    Filing Date: April, 30 2018

     

     


    Daily Technical Chart for (NASDAQ: CHEK)

    Daily Technical Chart for (NASDAQ: CHEK)


    Stay tuned for daily updates and more on (NASDAQ: CHEK)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: CHEK)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CHEK is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CHEK and does not buy, sell, or trade any shares of CHEK. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/